Sartorius Stedim Biotech said today it will ... specializes in design and development of small-scale, multi-parallel fermentation systems, particularly for biopharmaceutical applications.

Welcoming the acquisition, David Newble, CEO of TAP Biosystems, said, “As a market leader in bioprocessing technologies with a strong position in fermentation, Sartorius Stedim Biotech is well-placed ...

The latest balance sheet data shows that Sartorius Stedim Biotech had liabilities of €433.7m due within a year, and liabilities of €215.8m falling due after that. On the other hand ...

The ambr 250 mini benchtop bioreactor system from Sartorius Stedim Biotech can be used for parallel fermentation and cell culture. The ambr 250 mini benchtop bioreactor system from Sartorius Stedim ...

Biopharmaceutical Fermentation Market Projected Population With Diabetes In M Illion Global 2021 2045 Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Market Size ...

In 2018, the company made a commitment to provide the University with state-of-the-art fermentation technologies and named the Sartorius Fermentation Gallery, an integral part of the CSL Behring ...